TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2134265-2010-04658
- Event Type
- Injury
- Date Received
- October 19, 2010
- Date of Event
- June 16, 2010
- Report Date
- September 28, 2010
- Manufacturer
- BOSTON SCIENTIFIC - GALWAY
- Product Code
- NIQ
- PMA / PMN Number
- P060008
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4).
PATIENTS DATE OF BIRTH (B)(6).
DEVICE IS A COMBINATION PRODUCT. DEVICE EVALUATED BY MANUFACTURER. IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).
SAME CASE AS 2134265-2010-05581 AND 2134265-2010-05582. IT WAS FURTHER REPORTED THAT THE LESION BEING TREATED IN THE INDEX PROCEDURE WAS A 3.00MM, 50.0MM LONG 90% STENOSED. THE PHYSICIAN TREATED THE LESION WITH PRE-DILATATION, AND SUCCESSFULLY IMPLANTING THREE (3.00X28MM, 3.00X12MM AND A 2.50X12MM) TAXUS LIBERTE STENTS WITHOUT GAP, AND POST-DILATATION. RESIDUAL STENOSIS BECAME VISUALLY 0% AND TIMI-3 FLOW HAD BEEN KEPT SINCE PRE-INDEX PROCEDURE. THE PATIENT WAS DISCHARGED WITHOUT COMPLICATIONS TWO DAYS LATER ON ASPIRIN AND CLOPIDOGREL BISULFATE. 264 DAYS POST-INDEX PROCEDURE, THE PATIENT EXPERIENCED ANGINA. PCI WAS PERFORMED. THE TARGET LESION WAS VISUALLY 90% STENOSED. THE PHYSICIAN TREATED THE LESION WITH BALLOON ANGIOPLASTY AND PLACEMENT OF A NON BSC STENT. RESIDUAL STENOSIS BECAME 0%. THE PATIENT WAS DISCHARGED THE NEXT DAY.
SAME CASE AS 2134265-2010-05581 AND 2134265-2010-05582. IT WAS FURTHER REPORTED THAT THE LESION BEING TREATED IN THE INDEX PROCEDURE WAS A 3.00MM, 50.0MM LONG 90% STENOSED. THE PHYSICIAN TREATED THE LESION WITH PRE-DILATATION, AND SUCCESSFULLY IMPLANTING THREE (3.00X28MM, 3.00X12MM AND A 2.50X12MM) TAXUS LIBERTE STENTS WITHOUT GAP, AND POST-DILATATION. RESIDUAL STENOSIS BECAME VISUALLY 0% AND TIMI-3 FLOW HAD BEEN KEPT SINCE PRE-INDEX PROCEDURE. THE PATIENT WAS DISCHARGED WITHOUT COMPLICATIONS TWO DAYS LATER ON ASPIRIN AND CLOPIDOGREL BISULFATE. AT 264 DAYS POST-INDEX PROCEDURE, THE PATIENT EXPERIENCED ANGINA. PCI WAS PERFORMED. THE TARGET LESION WAS VISUALLY 90% STENOSED. THE PHYSICIAN TREATED THE LESION WITH BALLOON ANGIOPLASTY AND PLACEMENT OF A NON BSC STENT. RESIDUAL STENOSIS BECAME 0%. THE PATIENT WAS DISCHARGED THE NEXT DAY.
(B)(4). IT WAS REPORTED THAT FOLLOWING A CORONARY ARTERY TREATMENT PROCEDURE THE PATIENT EXPERIENCED ANGINA. THE LESION BEING TREATED WAS LOCATED IN THE MID LEFT ANTERIOR DESCENDING ARTERY. THE PHYSICIAN IMPLANTED A TAXUS LIBERTE STENT OF UNKNOWN SIZE IN THE LESION. IN (B)(6) 2010, THE PATIENT DEVELOPED ANGINA PECTORIS. NINE-MONTH FOLLOW-UP ANGIOGRAPHY WAS PERFORMED. RESULTS REVEALED THE TARGET VESSEL DIAMETER WAS 3.00MM, 35MM LONG WITH 90% STENOSIS. THE PHYSICIAN PERFORMED A TVR USING AN UNKNOWN BALLOON CATHETER AND UNKNOWN SIZE NON BSC STENT WITH RESIDUAL STENOSIS BEING 0%. THE PATIENT WAS DISCHARGED 2 DAYS LATER WITH THE PATIENTS SYMPTOMS IMPROVED. THERE WAS NO ANGINAL SYMPTOMS REPORTED AT THE 1 YEAR FOLLOW-UP.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TAXUS LIBERTE PACLITAXEL-ELUTING CORONARY STENT SYSTEM | CORONARY DRUG-ELUTING STENT | NIQ | BOSTON SCIENTIFIC - GALWAY | H7493893628300 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 79 YR | Required Intervention | 3.00X12MM TAXUS LIBERTE STENT| 2.50X12MM TAXUS LIBERTE STENT |